首页 | 本学科首页   官方微博 | 高级检索  
检索        

P糖蛋白与配体相互作用的结构基础及其肿瘤耐药逆转的研究
引用本文:赵青,黎燕,彭晖.P糖蛋白与配体相互作用的结构基础及其肿瘤耐药逆转的研究[J].国外医学(药学分册),2010(6):439-445.
作者姓名:赵青  黎燕  彭晖
作者单位:[1]军事医学科学院基础医学研究所四室,北京100850 [2]南开大学医学院,天津300071
基金项目:国家自然科学基金资助项目(30873083)
摘    要:P糖蛋白(P-glycoprotein,P-gp)是一种多药外排转运体,对控制各种抗癌药物的生物学活性具有重要意义。P-gp转运体作为生理屏障阻滞药物渗透,从而使药物发挥效应受限。传统的化疗增敏剂通过对转运体的调节可有效改善抗肿瘤药物的药代动力学并逆转多药耐药。本文将简要概述近年来有关P-gp与配体相互作用的结构信息以及肿瘤耐药逆转策略的研究进展。

关 键 词:多药耐药  P糖蛋白  药物外排  逆转剂

Structure basis of P-gp-ligands interaction and reversal of P-gp-mediated multidrug resistance
ZHAO Qing,LI Yan,PENG Hui.Structure basis of P-gp-ligands interaction and reversal of P-gp-mediated multidrug resistance[J].Foreign Medical Sciences(Section of Pharmarcy),2010(6):439-445.
Authors:ZHAO Qing  LI Yan  PENG Hui
Institution:1. Institute of Basic Medical Science, Academy of Military Medical Sciences, Beijing 100850, China; 2. School of Medicine, Nankai University, Tianjin 300071, China)
Abstract:P-glycoprotein(P-gp) is a multi-drug efflux transporter that plays a significant role in governing the bioavailability of various anti-cancer drugs. P-gp transporter impedes the permeability of drugs through physiological barriers resulting in limited pharmacological response. Modulation of this efflux transporter by various traditional "chemosensitizers" forms a distinctive approach in improving pharmacokinetics and conquering drug resistance. This review summarizes the recent advances in structural information of P-gp interactions with investigated ligands and new strategies to improve the poor efficiency in chemotherapy.
Keywords:multi-drug resistance  P-glycoprotein  drug efflux  reversal agents
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号